Dehong Yu Selected Research

Hearing Loss (Hearing Impairment)

6/2022	An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity.
1/2022	The disruption and hyperpermeability of blood-labyrinth barrier mediates cisplatin-induced ototoxicity.
1/2020	Current Strategies to Combat Cisplatin-Induced Ototoxicity.
1/2019	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
1/2018	A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss.
4/2016	Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
1/2015	A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dehong Yu Research Topics

Disease

7	Ototoxicity 06/2022 - 04/2016
7	Hearing Loss (Hearing Impairment) 06/2022 - 01/2015
4	Neoplasms (Cancer) 01/2022 - 01/2019
1	Hypoxia (Hypoxemia) 01/2022
1	Atrophy 01/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Bone Resorption 01/2020
1	Triple Negative Breast Neoplasms 10/2017
1	Labyrinth Diseases 04/2016
1	Sensorineural Hearing Loss 04/2016
1	Asthma (Bronchial Asthma) 01/2014
1	Inflammation (Inflammations) 01/2014
1	Metaplasia 01/2014
1	Colorectal Neoplasms (Colorectal Cancer) 02/2002
1	Hamartoma 02/2002
1	Carcinoma (Carcinomatosis) 02/2002
1	Adenoma (Adenomas) 02/2002
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 02/2002
1	Polyps 02/2002

Drug/Important Bio-Agent (IBA)

8	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 01/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 01/2019
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2015
2	AntioxidantsIBA 06/2022 - 03/2020
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2019 - 01/2015
2	poly(lactide) (polylactic acid)IBA 04/2016 - 01/2015
1	astaxanthine (astaxanthin)IBA 06/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	PlatinumIBA 03/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	HydrogelsIBA 01/2019
1	Silk FDA Link 01/2019
1	Polyethylene (Polythene)IBA 01/2019
1	CateninsIBA 10/2017
1	Long Noncoding RNAIBA 10/2017
1	SteroidsIBA 04/2016
1	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 04/2016
1	Broncho-VaxomIBA 01/2014
1	CytokinesIBA 01/2014
1	Bacterial LysatesIBA 01/2014
1	ParaffinIBA 02/2002
1	beta CateninIBA 02/2002

Therapy/Procedure

3	Therapeutics 03/2020 - 04/2016
2	Drug Therapy (Chemotherapy) 03/2020 - 04/2016
1	Radiotherapy 01/2020
1	Injections 01/2019
1	Oral Administration 01/2014